Comparison of HLA-identical sibling bone marrow transplants (BMT) versus interferon plus cytarabine (IFN/Ara-C) for chronic myelogenous leukemia (CML) in chronic phase (CP).

被引：0
|
作者：
Guilhot, F
Sobocinski, K
Guilhot, J
Zhang, M
Giralt, S
Harousseau, JL
Michallet, M
Maloisel, F
Blaise, D
Guerci, A
Horowitz, M
机构：
[1] CHRU, France Intergrp LMC, Poitiers, France
[2] Med Coll Wisconsin, Int Bone Marrow Transplant Registry, Milwaukee, WI 53226 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2343
引用
收藏
页码：545A / 545A
页数：1
相关论文
共 50 条
  • [21] Unexpected late graft failure 9 months after HLA-identical bone marrow transplant (BMT) for chronic myeloid leukemia (CML):: treatment with a second BMT
    Gil-Fernández, JJ
    Arranz, R
    Cámara, R
    Alegre, A
    Figuera, A
    Fernández-Rañada, JM
    HAEMATOLOGICA, 1998, 83 (03) : 285 - 287
  • [22] Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the International Bone Marrow Transplant Registry
    Giralt, S
    Szydio, R
    Goldman, JM
    Veum-Stone, J
    Biggs, JC
    Herzig, RH
    Klein, JP
    McGlave, PB
    Schiller, G
    Gale, RP
    Rowlings, PA
    Horowitz, MM
    BLOOD, 2000, 95 (02) : 410 - 415
  • [23] HLA-Identical Sibling Compared With 8/8 Matched and Mismatched Unrelated Donor Bone Marrow Transplant for Chronic Phase Chronic Myeloid Leukemia
    Arora, Mukta
    Weisdorf, Daniel J.
    Spellman, Stephen R.
    Haagenson, Michael D.
    Klein, John P.
    Hurley, Carolyn K.
    Selby, George B.
    Antin, Joseph H.
    Kernan, Nancy A.
    Kollman, Craig
    Nademanee, Auayporn
    McGlave, Philip
    Horowitz, Mary M.
    Petersdorf, Effie W.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1644 - 1652
  • [24] Late Mortality and Relapse following BuCy2 and HLA-Identical Sibling Marrow Transplantation for Chronic Myelogenous Leukemia
    Copelan, Edward A.
    Crilley, Pamela Ann
    Szer, Jeffrey
    Dodds, Anthony J.
    Stevenson, Dustin
    Phillips, Gary
    Elder, Patrick
    Nivison-Smith, Ian
    Avalos, Belinda R.
    Penza, Sam
    Topolsky, David
    Sobecks, Ronald
    Kalaycio, Matt
    Bowell, Brian J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (07) : 851 - 855
  • [25] Treatment with α-interferon (IFN) plus intermittent oral Ara-C (YNK-01) in chronic myeloid leukemia (CML) patients resistant to IFN.
    Cervantes, F
    Sureda, A
    Hernández-Boluda, JC
    Brunet, S
    Borrego, D
    Antich, JL
    Martino, R
    Montserrat, E
    BLOOD, 2001, 98 (11) : 255B - 255B
  • [26] Absence of influence of prior interferon alfa (IFN alpha) therapy on the outcome of allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML).
    Tomas, IF
    Steegman, IL
    Requena, MI
    Soria, VGG
    FernandezRanada, IM
    BLOOD, 1995, 86 (10) : 3859 - 3859
  • [27] Interferon alpha2b (IFN) and cytarabine (Ara-C) survival and cytogenetic response in chronic leukemia (CML). Results of a randomized trial.
    Guilhot, F
    Chastang, C
    Guerci, A
    Michallet, M
    Harousseau, JL
    Maloisel, F
    Briere, J
    Bouabdallah, R
    Guyotat, D
    Tertian, G
    Nicolini, F
    Abgrall, JF
    Navarro, M
    Blanc, M
    Brice, P
    Simon, M
    Ifrah, N
    Rochant, F
    Vilque, JP
    Delain, M
    Guilhot, J
    Tanzer, J
    BLOOD, 1996, 88 (10) : 551 - 551
  • [28] Prognostic relevance of acute graft-versus-host disease (AGvHD) on outcome in patients transplanted with HLA-identical sibling transplants for chronic myeloid leukemia (CML) in first chronic phase.
    Gratwohl, A
    Brand, R
    Apperley, J
    Biezen, AV
    Devergie, A
    deWitte, T
    Frassoni, F
    Guglielmi, C
    Michallet, M
    Kolb, H
    Ruutu, T
    Niederwieser, D
    BLOOD, 2000, 96 (11) : 193A - 193A
  • [29] Early treatment decisions with interferon alpha (IFN-A) therapy in early chronic phase chronic myelogenous leukemia (CP-CML).
    Sacchi, S
    Kantarjian, K
    Smith, T
    OBrien, S
    Pierce, S
    Kornblau, S
    Beran, M
    Keating, M
    Talpaz, M
    BLOOD, 1997, 90 (10) : 2303 - 2303
  • [30] T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation
    Drobyski, WR
    Hessner, MJ
    Klein, JP
    Kabler-Babbitt, C
    Vesole, DH
    Keever-Taylor, CA
    BLOOD, 1999, 94 (02) : 434 - 441
12345